How Will Payers Manage the Cost of New, Advanced Biologic and Oncologic Agents as Therapy Areas Become Crowded with Drugs with Similar Mechanisms of Action?
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.070
https://www.valueinhealthjournal.com/article/S1098-3015(17)30404-7/fulltext
Title :
How Will Payers Manage the Cost of New, Advanced Biologic and Oncologic Agents as Therapy Areas Become Crowded with Drugs with Similar Mechanisms of Action?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30404-7&doi=10.1016/j.jval.2017.08.070
First page :
A409
Section Title :
BREAKOUT SESSION XIV
Open access? :
No
Section Order :
53